A new USC Schaeffer Center white paper finds expanded access to anti-obesity medications would lead to significant increases ...

Adding an anti-obesity medication just one month after behavioral therapy begins—rather than waiting the currently ...

Adding an anti-obesity medication just one month after behavioral therapy begins-rather than waiting the currently recommended six months-can more than double weight loss for patients who struggle ...

A new University of Michigan study shows that a strong majority of older Americans want health insurance — including Medicare — to cover weight loss medica ...

Both semaglutide and tirzepatide would need big price cuts to be seen as a good buy for the US healthcare system.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Fashion influencer Remi Bader just revealed she underwent a weight loss surgery that cut 80 percent of her stomach amid ...

State lawmakers are considering expanding the types of obesity treatments covered by Nevada Medicaid, including approving ...

Mounjaro, a weight loss drug launched by Eli Lilly in India, could be a game-changer and has been making waves lately. Here's ...

Eli Lilly's much-anticipated drug for diabetes and obesity, that competes with Ozempic globally, is now in India. Here's what ...

Former Citigroup CEO Sandy Weill has donated $50 million to launch a cancer research hub focusing on how diet and metabolism ...

A new USC Schaeffer Center white paper finds expanded access to anti-obesity medications would lead to significant increases in life expectancy and disease-free years while generating a ...